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movement after stroke: a systematic review of
clinical studies
Marika Noorkõiv1,2*, Helen Rodgers1 and Christopher I Price1Abstract
The aim of this review was to identify and summarise publications, which have reported clinical applications of upper
limb accelerometry for stroke within free-living environments and make recommendations for future studies. Data was
searched from MEDLINE®, Scopus, IEEExplore and Compendex databases. The final search was 31st October 2013. Any
study was included which reported clinical assessments in parallel with accelerometry in a free-living hospital or home
setting. Study quality is reflected by participant numbers, methodological approach, technical details of the equipment
used, blinding of clinical measures, whether safety and compliance data was collected. First author screened articles for
inclusion and inclusion of full text articles and data extraction was confirmed by the third author. Out of 1375
initial abstracts, 8 articles were included. All participants were stroke patients. Accelerometers were worn for either
24 hours or 3 days. Data were collected as summed acceleration counts over a specified time or as the duration
of active/inactive periods. Activity in both arms was reported by all studies and the ratio of impaired to unimpaired arm
activity was calculated in six studies. The correlation between clinical assessments and accelerometry was tested in five
studies and significant correlations were found. The efficacy of a rehabilitation intervention was assessed using
accelerometry by three studies: in two studies both accelerometry and clinical test scores detected a post-treatment
difference but in one study accelerometry data did not change despite clinical test scores showing motor and functional
improvements. Further research is needed to understand the additional value of accelerometry as a measure of upper
limb use and function in a clinical context. A simple and easily interpretable accelerometry approach is required.
Keywords: Motion, Technology, Neurological conditionsIntroduction
Body worn motion sensors provide an opportunity for
non-invasive, objective and accurate observation of pa-
tients’ movements during research and clinical re-
habilitation [1-6]. These range from simple physical
activity monitors (e.g. pedometers) [1] to more complex
instruments that can capture precise limb position in a
three-dimensional space (e.g. a combined accelerometer-
gyroscope-magnetic field) [2]. The continuous development
of technology and data analysis methods has resulted in an
increasing number of proof-of-concept and validation
studies [3,4]. However for motion sensor approaches to
fully explore recovery mechanisms or assist clinicians* Correspondence: marika.noorkoiv@adeli.ee
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reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.during therapeutic decision-making, they must reflect
patient activity in real world settings.
Being small, light and affordable, accelerometers are
an attractive technology for measurement of upper ex-
tremity movement. As loss of arm function is common
after stroke [5], they have already been used to record
activity (i.e. the amount of use per time unit) [7] and/or
discriminate active from inactive periods [6,8]. Although
the information derived from standard accelerometers
is limited to changes in speed and direction, if thera-
peutic applications are demonstrated in hospital and
home settings then a large number of patients could
benefit.
A broad systematic review of accelerometer applications
after stroke has previously reported that accelerometers
yield valid and reliable data about the physical activity
of patients, but the clinical implications were unclearal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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was undertaken in October 2008 and has not been re-
peated to include more recent publications which focus
on clinically relevant outcomes. Subsequent studies have
included a heterogeneous range of upper limb impairment
and function measures, and used a variety of statistical ap-
proaches to examine for associations with different accel-
erometer data formats. Consequently it is difficult to
appreciate the current state of development of clinical ac-
celerometer applications.
The aim of this systematic review was to identify and
summarise publications that have reported clinical appli-
cations of upper limb accelerometry amongst stroke
populations within free-living hospital or home environ-
ments, and thereby make recommendations for future
clinical practice and research. To maintain clinical rele-
vance, we sought to include only studies from real-world
settings which reported clinical assessments in parallel
with motion data.
Review
Methods
We systematically searched the published literature re-
garding the use of upper limb accelerometry amongst
stroke patients to answer the following questions:
(1) What are the clinically relevant research
applications of upper limb accelerometers in a
free-living hospital or home environment?
(2) What types of accelerometers have been described
and how were they used?
(3) How was data collected and analysed?
(4) How do the data measurements obtained relate to
clinical assessments in a way that would be useful
for clinicians and researchers?
The inclusion criteria were peer-reviewed original stud-
ies that (1) used movement sensors in a stroke population
from a free-living clinical or domiciliary setting, (2) cre-
ated a kinematic description of upper limb movement
from sensor data, (3) used stand-alone accelerometers
which did not require an external reference point (e.g. an
electromagnetic field), (4) compared the kinematic data
with a clinical assessment of impairment or function. We
did not include articles that reported data (1) only relating
to validity, reliability or algorithm and/or sensor develop-
ment without any clinical comparison, (2) from sensors
used in a visual feedback system or video game, (3) reflect-
ing modification of the accelerometer output by other de-
vices (e.g. from a separate gyroscope), and (4) where
movement was limited to a very specific environment,
function and/or task e.g. during performance of a subset
of upper limb motor tasks from the Fugl-Meyer Assess-
ment [10] or only during reaching [7]. Due to the smallnumber of publications anticipated, all research designs
were included and study quality was not formally rated.
However quality is reflected by the study information re-
ported including participant numbers, population details
provided, methodological approach taken, technical de-
scription of the equipment used, blinding of clinical
measures and whether safety and compliance data were
collected.
The search strategy used for all databases is described
in Appendix 1. Electronic databases were searched on-
line through the Newcastle University library system:
MEDLINE® (1946 to October Week 4 2013), Scopus (All
years –October 2013), IEEExplore (1999–2013), and
Compendex (1884–2014). The final search was 31st
October 2013. The first author initially screened articles
for inclusion based upon title and abstract, removed
duplicates, retrieved full-text papers and selected final
articles according to the inclusion and exclusion criteria
(Figure 1). Inclusion of full text articles and data extrac-
tion was confirmed by the third author.
Results
Upper limb accelerometry applications in clinical stroke
research
Eight articles fitted the inclusion criteria (Table 1). All
included stroke patients without other neurological con-
ditions represented. Three described rehabilitation inter-
ventions where accelerometer data were collected to
explore mechanisms and/or as an outcome measure,
including two randomised controlled trials. Age range
was reported by three studies (35 to 94 years) [8,11,12]
and the average age was reported by five studies [13-17]
(Table 1). Gender distribution favoured male and was
65% overall. The inclusion criteria for studies were six
mild to moderate [8,11-14] and one severe [15] upper
extremity impairment. The level of motor impairment
was not reported [16]. Patients with excessive spasticity
were excluded in two studies [13,17], shoulder pain was
an exclusion for two studies [15,17] and wheelchair bound
participants were excluded by one study [8]. Participants
were required to have no or minimal cognitive deficit in
all studies.
Applications of accelerometers in the selected studies
were grouped into four main categories: (1) description of
upper limb usage after stroke [11]; (2) assessment of the
effect of therapeutic interventions such as robot-assisted
therapy [17], constraint-induced movement therapy [16]
and sub-acute stroke rehabilitation [15]; (3) comparison of
real-world upper limb use with various measures of upper
limb impairment and function; and (4) examination of the
reliability and validity of a specific clinical scale such as
the ABILHAND questionnaire [13] and Motor Activity
Log [14]. No studies were identified which used acceler-
ometer output to modify a therapeutic intervention in the
Figure 1 Flow of information through the different search phases of a systematic review based on PRISMA 2009 guidelines. Four
search engines (i.e. MEDLINE, Scopus, IEEExplore and Compendex) were used to identify the relevant literature. After the screening based on title
and abstract and removal of duplicates, 18 articles were selected. After the selection based on the full text article, 8 final articles were included in
the current review.
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ported only in the study by Liao et al. [17]: “all 20 study
participants completed the study and no discomfort
when wearing the device was reported and overall com-
pliance was good”.
Accelerometer type, site and duration
Three studies used tri-axial accelerometers [8,16,17], one
study two-axial [14], two studies uni-axial accelerometers
[11,12] and the type of the accelerometer were not re-
ported by two studies [13,15]. All participants wore accel-
erometers on both wrists for either a single 24 hr period
[11-13] or 3 consecutive days [8,14-17]. Only Lang et al.
explained their choice of data collection period: “the
24 hour period was chosen because: 1) that is the length
of the day, enabling to capture activity that might occur
outside of the typical workday or therapy hours, and 2)
people with hemiparesis and controls were less interested
in participating or less-compliant with wearing them if
they had to be worn for longer periods” [11].
Accelerometry data collection and analysis
Data were collected either as the summed acceleration
counts over a specified time [8,14,16,17], or as dichoto-
mized data representing the duration of active and inactive
periods [11,12]. Different approaches were reported
for defining a unit of arm activity, with data capture
epochs varying from 1 second to 1 minute. Activity of bothimpaired and unimpaired upper extremities were measured
and reported in all studies. A ratio of impaired to unim-
paired arm activity was calculated for all studies except
Rand et al. [16] and Lang et al. [12]. Two studies ex-
plained their choice for using a ratio as a main outcome
measure: Liao et al. [17] chose arm activity ratio be-
cause the mean activity value of each arm would be
subject to interference by other factors, such as walking
pattern [18]; Uswatte et al. [14] explained that acceler-
ometers were worn on both wrists during a trial of con-
straint induced movement therapy because a single unit
on the impaired arm might cue use of that extremity
and thereby confound measurement of treatment out-
come and previous validation studies had suggested
that the ratio of recordings controlled better for varia-
tions in overall levels of physical activity [1,19].
In two studies the participants were asked to keep a
diary to assist with accelerometry data analysis [8,12]:
Thrane et al. [12] asked participants to note in a diary
when accelerometers were removed, travel and sleep in
order to exclude these periods from analysis. Van der Pas
et al. [8] asked participants to record times for going to
sleep/getting up and trigger an event marker on the de-
vice. In the study by Rand et al. [16], a participant com-
pleted diary was not used but the activity counts of arm
swing while walking were eliminated (5 consecutive steps
or more in one epoch) to increase data specificity for goal
directed hand usage.
Table 1 Overview of the selected articles
Uswatte et al.
(2006) [6]
Lang et al.
(2007) [11]
Thrane et al.
(2011) [12]
Van der Pas et al.
(2011) [8]
Wang et al.
(2011) [13]
Rand et al.
(2012) [16]
Liao et al.
(2012) [17]
Taub et al.
(2013) [15]
Aim To study the
reliability and
validity of the
Motor Activity Log
for assessing real-
world quality of a
movement scale
(QOM) and
amount of use
scale (AOU) of the
hemiparetic arm
in stroke survivors.
To determine the
amount of arm
use in people
with hemiparesis
post stroke during
inpatient
rehabilitation. To
examine the
relationships
between upper
extremity use,
impairments and
activity limitations.
To investigate the
correlations
between arm
motor impairment
and real-world
use. To analyse
whether arm
movement ratio
(AMR) is
correlated with
impairment or
duration of arm
use. To assess the
influence of motor
impairment on
self-care activities.
To test whether
triaxial arm
accelerometry is a
valid method to
measure the
amount of upper
extremity activity
in the daily life of
adult stroke
survivors.
To investigate the
criterion-related
validity,
responsiveness,
and clinically
important
differences of the
ABILHAND
questionnaire in
patients with
stroke.
To determine the
change in daily
use of the upper
and lower
extremities of
stroke patients
during subacute
rehabilitation.
To compare the
effects of robot-
assisted therapy
on real-world arm
activity and daily
function in a dose-
matched (in
amount of hours)
control treatment
group.
To determine
whether patients
with functionless
hands would
improve everyday
use using a
combination of
Constraint-
Induced
Movement
Therapy (CIMT)
and conventional
techniques for
regulating tone.
Study design Multicenter clinical
trial.
Report. Cross-sectional
study.
Cross-sectional
concurrent validity
study.
Validation and
clinimetric study.
Observational
cohort.
Prospective
randomized
controlled trial.
Case series.
Blinding Single-blinded
(raters).
No. No. Not reported. Blinded raters. No. Double-blinded No.
Safety data Not reported. Not reported. Not reported. Not reported. Not reported. Not reported. Not reported. Not reported.
Sensors Two-axial
accelerometers
(Manufacturing
Technologies Inc.,
Fort Walton
Beach, FL).
Uni-axial
accelerometers
(model 7164–2.4
Activity Monitors,
MTI Health
Services, FL).
Uni-axial
ActiGraph GT1M
Accelerometers
(ActiGraph Inc.,
Pensacola, USA).
Tri-axial watch-like,
water-resistant
accelerometers
(Actiwatch AW7a).
Accelerometers
about the size of
a large wristwatch.
The type was not
reported.
Tri-axial
accelerometers
(ActicalTM, Mini
Mitter Co).
Tri-axial MicroMini-
Motion logger
(Ambulatory
Monitoring, New
York, NY, USA).
Accelerometers
were
not defined.
Placement 1 on each wrist. 1 on each wrist. 1 on each wrist. 1 around each
wrist.
1 on each wrist. 1 on each wrist. 1 on each wrist. 1 on each arm.
Wearing time 3 days during all
waking hours,
except when in
contact with
water.
Single 24 h
period, except for
times when the
devices would be
exposed to water.
Single 24 h
period.
Continuously for
3 days.
All day (not
specified by
authors for how
long).
3 days on
admission for
rehabilitation and
3 weeks later prior
to discharge.
Could remove at
night.
3 days before/after
the intervention,
except when in
contact with
large amounts of
water.
3 days before and
after
each phase of the
treatment.
Participants 222 34 31 45 51 60 20 6
Age 62.2 ± 13.0 63.9 ± 14.8 (range:
39–94)
65 ± 14 59.4 ± 9.2 (range:
39–80)
55.26 ± 10.31 61.0 ± 13.3 55.51 ± 11.17 56.9 ± 9.8
Men (%) 64 41 71 64 67 68 60 83
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Table 1 Overview of the selected articles (Continued)
Time since
stroke
3-12 months 9.3 ± 4.2 days 10.6 ± 6 days 2.6 ± 1.6 years 17.57 ±
13.43 months
33.4 ± 2.7 days 23.90 ±
13.39 months
5.1 ± 6.8 years
Setting Outside the
laboratory.
During in-patient
rehabilitation.
Normal
community-
dwelling activity.
Normal
community-
dwelling activity.
Normal
community-
dwelling activity.
Normal
community-
dwelling activity.
Normal community-
dwelling activity.
Normal
community-
dwelling daily
activity.
Accelerometer
activity
measures
The ratio of
duration of more-
to less-impaired
arm activity.
Duration of less-
impaired-arm
activity as a% of
the recording
period (the
number of epochs
in the less-
impaired arm data
with above-
threshold values
divided by the
total number of
epochs).
Duration of
impaired and
unimpaired upper
extremity usage
during a 24 hr
period.
(1) Duration of
arm use, (2) The
ratio of arm use
duration between
the more and less
affected arm
(AMR).
(1) The total sum
of acceleration
counts during
waking hours
divided by the
number of waking
hours. (2) Bilateral
arm activity: the
ratio of the sum
of daytime accele-
ration of the
impaired arm to
the unimpaired
arm.
Ratio of affected
to unaffected arm
recordings.
The mean activity
counts for the
upper extremity
for 1) an entire
day, 2) a PT
session, 3) an OT
session and 4)
daily use not
including the OT/
PT sessions.
Ratio of mean
activity between
the impaired
and unimpaired
arm.
The ratio of more-
affected
to less-affected
arm recordings.
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The correlation between various clinical test scores and
upper limb accelerometry was examined in five studies
(Table 2). Accelerometry data correlated significantly with
most clinical tests of impairment such as active range of
motion [11], muscle strength [11], Fugl-Meyer Assess-
ment subscale for upper extremity [11], and with clinical
tests of upper extremity function such as Action Research
Arm Test (ARAT) [11], Wolf Motor Function Test
(WMFT) [11], Functional Independence Measure (FIM)
for motor and upper extremity function [11], different
scales of Motor Activity Log (MAL) [8,14], Stroke Impact
Scale (SIS) Hand Function Subscale [8], a test of manual
ability of the upper extremity ABILHAND [13] and
Nottingham Extended Activities of Daily Living (NEADL)
[13]. A lack of correlation was found with the Modified
Ashworth Scale [11], composite light touch [11], joint pos-
ition sense [11] and SIS Mobility Subscale [8].
Consistent with studies in controlled settings, Thrane
et al. [12] found a stronger correlation between a clin-
ical assessment of impairment (Fugl-Meyer Assessment
(FMA) and the movement duration ratio between the
least affected and more affected arm (r = −0.851, p <
0.001) than between the FMA and raw accelerometer
data (r = 0.601, p < 0.001). However Van der Pas et al.
[8] found a high correlation between unilateral (affected
arm) and bilateral (ratio) accelerometry (the number of
counts per time unit representing movement ‘intensity’)
and MAL-AOU (amount of use) and MAL-QOM (quality
of movement) scales, suggesting that both unilateral and
bilateral arm accelerometry are valid methods for asses-
sing arm activity related to function in daily life of patients
after stroke.
Thrane et al. [12] found a variation in arm movement
ratio (AMR) from accelerometer readings especially in
the upper range (less impairment) of FMA: in the FMA
range of 43–47, the AMR varied from a normal level of
1.2 to 2.5, indicating 2.5 times greater movement of the
less-affected arm which could indicate perceptual diffi-
culties or “learned non-use” amongst some participants.
No cofactors interfered with this relationship in the two-
factor regression models (age, gender, days since stroke,
initial stroke severity, apraxia, and lower extremity func-
tion). Hand dominance and choice of tasks could also
explain AMR variations in subjects with the same level
of motor function, however incomplete data prevented
the authors from further exploration of this finding and
the clinical implication is not clear [12].
The efficacy of an intervention was tested in three
studies [15-17] where accelerometry and clinical tests
data were collected in parallel. In two of these, the accel-
erometer data ratio between the impaired and unim-
paired arm and clinical test scores both detected a
difference from baseline to post-treatment [15,17]. TheFMA [15,17], MAL [15,17], Functional Independence
Measure [17] and active range of motion of the upper
limb [15] were used as outcome measures. However, in
the study by Rand et al. [16], there was a discrepancy be-
tween the clinical test scores and accelerometry: clinical
test scores showed motor and functional improvements
while upper extremity accelerometry data (mean activity
counts) did not change (Table 2). Although this discrep-
ancy may reflect methodological factors, accelerometer
data might be a better representation of real world activ-
ity, which is influenced by many more factors than just
motor performance.
Discussion
Measurement of upper extremity movement by accelero-
metry during day-to-day activities in hospital or at home
has the potential to provide additional valuable informa-
tion about recovery after stroke. The eight studies identi-
fied for the present review, including a large multicentre
clinical trial (n = 222) [14] and a prospective randomised
controlled trial (n = 20) [17], have demonstrated that
accelerometry can be systematically applied as a method
for measuring overall upper extremity activity. However it
is still uncommon that motion sensors are used to inform
the development of new clinical rehabilitation approaches.
Accelerometry data correlated well with the clinical tests
of impairment and function, apart from measures which
do not directly reflect upper limb motor function such as
tone, sensation and mobility. Only the study by Rand et al.
[16] reported that accelerometry failed to detect change in
upper extremity usage after a rehabilitation programme
whilst clinical tests showed a significant decrease in im-
pairment and improved function. Interestingly, this was
one of the two studies where the ratio of impaired to un-
impaired arm usage was not calculated and reported the
usage of impaired upper extremity only, but it should be
also considered that rehabilitation approach, patient mo-
tivation and learned non-use might be reasons why clin-
ical recovery is not reflected in daily upper limb activity
[16]. Improvements in stand-alone clinical assessments
without matching accelerometer readings might indicate
that participants have not translated motor recovery into
daily life. Rand et al. [16] suggested that the gap between
the recovery of capacity (i.e. clinical measurements) and
the lack of improvement in performance (i.e. daily use
of the upper extremities according to accelerometer
data) provides a useful guide for clinicians. If this is
demonstrated by appropriately designed studies then
feedback of accelerometer data to patients and clinicians
may have a therapeutic role. Improving the interpretation
of accelerometry data with clinical questionnaires (e.g. the
Motor Activity Log and ABILHAND) could allow re-
searchers to capture a wider spectrum of change in
daily function for stroke patients receiving rehabilitative
Table 2 Comparisons of accelerometer data and clinical scales
Uswatte et al.
(2006) [16]
Lang et al.
(2007) [10]
Thrane et al.
(2011) [12]
Van der Pas et al.
(2011) [8]
Wang et al.
(2011) [13]
Rand et al.
(2012) [16]
Liao et al.
(2012) [17]
Taub et al.
(2013) [15]
Statistical
approach
Type 3,1 intraclass
correlations.
Spearman
correlation
Spearman
correlation
Spearman correlation Pearson
correlations
Paired t-test ANCOVA Paired t-test
Accelerometer
data comparison
AMR Duration of use Duration of use
Calculated AMR
Activity counts
Calculated AMR
Calculated AMR Activity counts,
the upper
extremity
activity did not
change.
Calculated AMR.
The robot-assisted
therapy group improved
compared with the
active control group:
accelerometer F1,16=5.91,
p=0.026, effect size
r=0.26.
Calculated AMR.
Improved from baseline
to post-intervention:
t=2.9, p=0.016, d’=1.2
Clinical Measures of Impairment
AROM Shoulder flex
r=0.30, p<0.05,
elbow flex r=0.50,
p=0.01, wrist ext
r=0.63, p<0.01
Changed from baseline
to post-intervention:
t=6.1, p=0.001, d’=2.6.
FMS The duration of
use of the
affected arm:
r=0.60, p<0.001.
AMR: r=−0.85,
p<0.001
FMA improved:
t=−2.9, p=0.005
The robot-assisted
therapy group improved
compared with the
active control group:
FMA F1,16=14.32,
p=0.002, effect size
r=0.46
Change in FMA from
baseline to post-
intervention t=4.0,
p=0.005, d’=1.6
Modified Ashworth Scale r=−0.31, n.s
Pain Shoulder pain
r=0.41, p<0.01
Sensation Composite light
touch r=−0.15,
n.s., joint position
sense r=−0.03, n.s
Strength using a
hand-held
dynamometer
Shoulder flex
r=0.34, p<0.01,
elbow flex r=0.52,
p<0.01, wrist ext
r=0.37, p<0.01,
grip r=0.42,
p<0.01
Gait speed Improved: t=−4.8,
p<0.001
Clinical Measures of Function
ARAT r=0.40, p<0.01 Improved: t=−4.7,
p<0.001
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Table 2 Comparisons of accelerometer data and clinical scales (Continued)
FIM Motor r=0.67,
p<0.01, UE r=0.58.
p<0.01.
Improved: t=−7.6,
p<0.001
The robot-assisted
therapy group improved
compared with the
control group: FIM
F1,16=0.03, p=0.88, effect
size r=0.002
WMFT Function r=0.62,
p<0.01; time
r=−0.65, p<0.01
BBS BBS improved:
t=−6.4, p<0.001
6MWT 6MWT improved:
t=−4.8, p<0.001
Clinical Questionnaires
ABILHAND At baseline and
post treatment:
r=0.45–0.54,
p<0.01.
The robot-assisted
therapy group improved
compared with the
control group:
F1,16=4.76, p=0.043,
effect size r=0.22
MAL AMR was
correlated with
QOM r=0.52,
p<0.01 and AOU
r=0.47, p<0.01.
Less-impaired arm
accelerometry was
not correlated
with QOM r=0.14,
n.s. and AOU
r=0.14, n.s.
Bilateral arm activity
(mean of 2 arms):
MAL-26AOU Scale
r=0.37, p<0.01. MAL-
26AOU Scale r=0.37,
p<0.01.
The robot-assisted
therapy group improved
compared with the
control group: MAL AOU
F1,16=9.39, p=0.007,
effect size r=0.36, MAL
QOM F1,16=13.48,
p=0.002, effect size
r=0.44
Change in FL-MAL Arm
Use scale from baseline
to post-intervention:
t=7.4, p=0.001, effect
size(d’)=3.0
AMR: MAL-26AOU
Scale r=0.60, p<0.001,
MAL-26QOM Scale
r=0.66, p<0.001.
Affected arm activity:
MAL-26AOU Scale
r=0.58, p<0.001, MAL-
26QOM Scale r=0.65,
p<0.001.
Note: AMR – arm movement ratio, AROM - Active Range of Motion, ARAT – Action Research Arm Test, WMFT – Wolf Motor Function Test, FIM – Functional Independence Measure, FIM UE – FIM Upper Extremity,
FMS – Fugl-Meyer Scale, MAL – Motor Activity Log, LF-MAL – lower functioning MAL, MAL-26 QOM – MAL-26 Quality of Movement, MAL-26 AOU – MAL-26 Amount of Use, CIMT – Constraint-Induced Movement
Therapy, SIS – Stroke Impact Scale, NEADL – Nottingham Extended Activities of Daily Living, BBS – Berg Balance Scale, 6MWT – 6 Minute Walking Test.
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were asked to keep a diary describing their everyday activ-
ities such as periods of walking, sitting, driving car etc.
[8,12]. However, using activity log sheets in addition to
accelerometry will set certain limitations for study recruit-
ment due to the extra time, effort and motivation required
from participants and researchers, and is only feasible if
the participant can write, or a carer can reliably complete
log sheets on their behalf.
Accelerometry data were collected either during 24 hours
or 3 consecutive days, which was justified by only one au-
thor [11]. Other studies mostly referred to the published
protocols by Uswatte et al. [1,6] where data collection is
over three consecutive days, possibly because the acceler-
ometer continuous recording capacity is approximately
72 h. It is unclear how long accelerometry data should be
collected for in order to obtain a meaningful description of
upper extremity usage in a real-world environment [20,21].
It has been suggested that 7 to 10 and 14 to 21 days of as-
sessment are required to reliable observe (i.e. R = 0.80),
total activity in healthy men and women, respectively [22].
In contrast, 21 to 28 days are required for reliable observa-
tion of non-occupational activity patterns in healthy men
and women [22]. Measuring physical activity levels and
patterns of patients during neurological rehabilitation will
be more challenging, as the duration and amplitude of ac-
tivities will be limited by changes in motor function [11].
In community settings it has been shown that adults par-
ticipants are more active on Saturdays than Sundays
[22,23], and for a real-world examination of motor behav-
iour it would be important to balance the days of the week
[21].
Further interpretation of data still has limitations,
mainly because of contamination by other activities that
did not include purposeful arm movement e.g. walking.
Attempts have been made to overcome these limita-
tions by using special data collection and analysis
methods to prevent overestimation of upper extremity
use. Most of the studies included in the present review
defined upper extremity use as any time when acceler-
ometer data suggested movement. However there were
alternative approaches. Rand et al. [16] defined upper
extremity usage as the number of activity counts during
a specified time. Liao et al. [17] defined upper extremity
usage as the area under the transducer signal curve
proposing that this detected subtle change in hemiple-
gic arm activity and so was more appropriate for re-
habilitation studies than a threshold approach [9,24].
Six studies out of eight used the ratio of impaired to un-
impaired arm as the outcome of upper extremity usage
[8,11-14,17], three of the six studies reported the ratio
only [13,15,17]. Whilst the ratio can aid correction for the
variability in overall physical activity, its interpretation is
limited if the absolute activity of impaired and unimpairedarms is not reported. For example, Lang et al. [11] found
that the activity duration of the impaired arm was less
than unimpaired, however, the usage of both was less than
that of healthy controls. They also found that the hours of
dominant and non-dominant upper extremity use were
not different [11] and that affected and unaffected upper
extremity use was positively correlated, supporting obser-
vations that upper extremities are most often used to-
gether to perform bimanual tasks during daily activity
[11]. In addition, Van der Pas [8] found that movement of
the affected arm after stroke was related to performance
of functional activities when that arm was dominant pre-
stroke. Therefore when upper extremity usage is reported
as a ratio, the underlying data is still dependent upon
intra- and inter-individual variations in bilateral upper ex-
tremity activity. The personal choice of tasks attempted
will also influence conclusions which can be drawn when
comparing between individuals in real-world settings,
which has implications for use of accelerometry during re-
habilitation programmes where patient and therapist se-
lect repetitive movements from a menu, e.g. [25].
The type of sensors varied from uni- to multiple-axis
accelerometers. Although a strong positive correlation
between the output from uniaxial and multiple axis ac-
celerometers have been reported [2], the validity coeffi-
cients reported for multiple axis units have been higher
than those reported for uniaxial models [2]. Importantly,
it is impossible to calculate a minimal clinical difference
for arm use by a uniaxial accelerometer because they
only measure in a single plane of movement [9]. Thus,
multiple axis accelerometers should be preferred to uni-
axial devices.
Study limitations
Although we sought to identify studies in free-living ra-
ther than controlled laboratory settings, the patients in-
cluded were still not typical of the stroke population,
being younger than the average age of stroke occurrence
in UK (~ 75 y) [26] and more often male. There was a ten-
dency to use accelerometry amongst patients with moder-
ate to mild impairment. Time since stroke varied across a
large range and it is likely that contact with rehabilitation
services would have varied similarly. There was no data
safety or tolerance reported (except the comment by Liao
et al. [17]). These factors reduce the relevance of current
evidence for typical neurological rehabilitation popula-
tions. Identifying and overcoming difficulties that limit the
use of real-world accelerometry across a whole range of
patients will be a challenging but an important focus for
future studies.
Conclusions
Real-world usage of the upper extremity during stroke re-
habilitation is still not yet well described and we require
Noorkõiv et al. Journal of NeuroEngineering and Rehabilitation 2014, 11:144 Page 10 of 11
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of accelerometry against clinical measures which holds
meaning for clinicians and patients. Recommendations
from this review of recent studies are:
– Clinical measures are still required to provide
context for interpretation in case the individual’s
recovery is not reflected through real world
accelerometer data e.g. due to learned non-use
– The ratio between impaired and unimpaired sides is
the standard approach for upper limb accelerometry
but hand dominance might require further
consideration depending upon individually chosen
rehabilitation goals
– Diaries should be used for at least a proportion of
the monitoring period in order to relate individual
accelerometer data to background levels of activity.
– Simple, user-friendly cost-effective and easily inter-
pretable upper limb accelerometry methods are still
required if this is to be a useful tool to monitor pa-
tients’ progress alongside clinical assessments of
motor recovery.
Appendix 1: search strategy
MEDLINE: (stroke* and rehabilit* and accelerometer*).
mp. [mp = title, abstract, original title, name of sub-
stance word, subject heading word, keyword heading
word, protocol supplementary concept, rare disease
supplementary concept, unique identifier]
Scopus: TITLE-ABS-KEY(stroke* AND rehabilit* AND
accelerometer*)
IEEExplore: stroke* and rehabilit* and accelerometer*
Compendex: ((((stroke*) WN KY) AND ((rehabilit*)
WN KY)) AND ((accelerometer*) WN KY))
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